Midlothian, United Kingdom

Peter Morris

This inventor holds 2 USPTO granted patents. Top assignees: Biosyn Arzeimittel Gmbh, Biosyn Arzneimittel Gmbh. Active years: 2005-2007.


% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2005-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Peter Morris: Innovator in Mistletoe Lectin Research

Introduction

Peter Morris is a notable inventor based in Midlothian, GB. He has made significant contributions to the field of biotechnology, particularly in the area of mistletoe lectin research. With a total of 2 patents, his work has implications for pharmaceutical applications.

Latest Patents

Morris's latest patents include innovations related to recombinant mistletoe lectin. The first patent focuses on processes for the production of mistletoe lectin polypeptides in both homologous and heterologous host systems. It also covers nucleic acid molecules that encode these polypeptides and pharmaceutical compositions that include mistletoe lectin nucleic acids. The second patent similarly addresses isolated mistletoe lectin polypeptides and their pharmaceutical compositions, emphasizing the production processes and the nucleic acid molecules involved.

Career Highlights

Throughout his career, Peter Morris has worked with prominent companies such as Biosyn Arzneimittel GmbH. His expertise in biotechnology has allowed him to contribute to advancements in the production and application of mistletoe lectins.

Collaborations

Morris has collaborated with notable professionals in his field, including Thomas Stiefel and Wolfgang Voelter. These collaborations have further enriched his research and development efforts.

Conclusion

Peter Morris stands out as an innovator in the field of mistletoe lectin research, with a focus on pharmaceutical applications. His contributions through patents and collaborations highlight the importance of his work in biotechnology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…